5 Things Imran Khan Has Done To Improve Pakistan

5 Things Imran Khan Has Done To Improve Pakistan 1:- Ensure Pakistan is Business Friendly 5 things Imran Khan has done to improve Pakistan the Prime Minister has tirelessly worked to encourage wealthy individuals and governments to invest in Pakistan. During his recent visit to the USA, the Prime Minister invited investors and businessmen from abroad to take advantage of the business […]

Positive new data for Johnson & Johnson single-shot COVID-19 vaccine on activity against Delta variant and long-lasting durability of response

Johnson & Johnson announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two preprint study summaries have been […]

Best 10 Diecast Cars in the World

Best 10 Diecast Cars in the World – Best Diecast Cars To Collect Best 10 diecast cars in the world it is no secret that the world has been obsessed with cars for a long time. Automobiles have been at people’s forefront of attention since the early 1900s. In honour of them, diecast models were made from classic or notable cars. These replicas […]

A step forward for IVF patients with low success rates

Fertility patients who have a poor response to ovarian stimulation represent a stubborn challenge in IVF. Few eggs are collected, success rates are low, and several treatments are usually needed to achieve pregnancy. Some patients eventually abandon treatment without success. Now, however, a study assessing two cycles of ovarian stimulation and two egg collections in the same menstrual cycle may […]

EMA gives green light for 8 new medicines

The European Medicine Agency’s key decision-making committee on human medicines (CHMP), has recommended eight medicines for approval at its June meeting.  The Committee recommended granting a conditional marketing authorisation for Abecma (idecabtagene vicleucel) for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three previous therapies, and whose cancer has worsened since receiving the last treatment. […]